Daniel Marcel Legault - Net Worth and Insider Trading
Daniel Marcel Legault Net Worth
The estimated net worth of Daniel Marcel Legault is at least $301,972 dollars as of 2024-11-08. Daniel Marcel Legault is the Senior Officer of Antibe Therapeutics Inc and owns about 983,296 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $290,072. Daniel Marcel Legault is also the Director of NeuPath Health Inc and owns about 70,000 shares of NeuPath Health Inc (TSXV:NPTH) stock worth over $11,900. Details can be seen in Daniel Marcel Legault's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Marcel Legault has not made any transactions after 2022-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Marcel Legault
Daniel Marcel Legault Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Marcel Legault owns 2 companies in total, including Antibe Therapeutics Inc (TSX:ATE) , and NeuPath Health Inc (TSXV:NPTH) .
Click here to see the complete history of Daniel Marcel Legault’s form 4 insider trades.
Insider Ownership Summary of Daniel Marcel Legault
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ATE | Antibe Therapeutics Inc | 2022-11-15 | Senior Officer |
| TSXV:NPTH | NeuPath Health Inc | 2021-08-31 | Director |
Daniel Marcel Legault Latest Holdings Summary
Daniel Marcel Legault currently owns a total of 2 stocks. Among these stocks, Daniel Marcel Legault owns 983,296 shares of Antibe Therapeutics Inc (TSX:ATE) as of November 15, 2022, with a value of $290,072 and a weighting of 96.06%. Daniel Marcel Legault also owns 70,000 shares of NeuPath Health Inc (TSXV:NPTH) as of August 31, 2021, with a value of $11,900 and a weighting of 3.94%.
Latest Holdings of Daniel Marcel Legault
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:ATE | Antibe Therapeutics Inc | 2022-11-15 | 983,296 | 0.30 | 290,072 |
| TSXV:NPTH | NeuPath Health Inc | 2021-08-31 | 70,000 | 0.17 | 11,900 |
Holding Weightings of Daniel Marcel Legault
Daniel Marcel Legault Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Marcel Legault has made a total of 15 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 10 buys and 5 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 40,000 shares on November 15, 2022, which cost Daniel Marcel Legault around $19,400.
According to the SEC Form 4 filings, Daniel Marcel Legault has made a total of 1 transactions in NeuPath Health Inc (TSXV:NPTH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NeuPath Health Inc is the acquisition of 20,000 shares on August 31, 2021, which cost Daniel Marcel Legault around $12,600.
Insider Trading History of Daniel Marcel Legault
- 1
Daniel Marcel Legault Trading Performance
GuruFocus tracks the stock performance after each of Daniel Marcel Legault's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Marcel Legault is -22.8%. GuruFocus also compares Daniel Marcel Legault's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Marcel Legault within 3 months outperforms 2 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Marcel Legault's insider trading performs compared to the benchmark.
Performance of Daniel Marcel Legault
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -19.06 | | | | | |
| Relative Return to S&P 500(%) | -19.08 | | | | | |
Daniel Marcel Legault Ownership Network
Ownership Network List of Daniel Marcel Legault
Ownership Network Relation of Daniel Marcel Legault
Daniel Marcel Legault Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
Daniel Marcel Legault is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
Daniel Marcel Legault Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Marcel Legault. Currently GuruFocus does not have mailing address information for Daniel Marcel Legault.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
